C5 Global Summit on Biosimilars


The European biosimilar market is expected to grow robustly in the next five years. A significant number of blockbuster biologics are scheduled to lose patent protection before 2025 creating huge opportunities for the entrance of biosimilar drugs across the continent. In light of these developments, C5 will present its inaugural Global Legal and Regulatory Summit on Biosimilars. Fish attorney Brian Coggio, who has lectured and written extensively on biosimilars and other life sciences topics, will discuss “Biosimilar Patent Litigation: Major Considerations for Success in Europe and the U.S.”

December 3-4, 2019
Westin Grand Munich
Munich, Germany